Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (1912)	3/4/1999 8:19:00 PM
From: M. Ramle	Read Replies (2) \| Respond to of 10280

Dale: I don't mean to scare you, but the March Options expire on March 20th, which is two weeks from tomorrow and NOT next Friday. I hope you realize that any major announcement during these two weeks, could strip you of your very very valuable SEPR shares !!!!! My technical indicators still point to a major breakout to the upside, and I would NOT be surprised to see SEPR set a new all-time high in the upper $140's - lower $150's range very soon. Here are some of the reasons I am personally expecting to push the price higher: 1. Stock Split; 2. Final FDA approval for Levalbuterol; 3. Major announcement for another joint-venture agreement; and/or 4. Technical breakout on the chart, which is showing once again strong accumulation. Any one of the above events could easily take us above the $139 mark. Be careful when selling Covered Calls !!!!! Anyway, Good Luck. Mazen